Cambridge Cognition – An excellent year for the company (Interview)

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won a series of contracts from a global pharmaceutical company to provide specialist clinical trial management

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it will be joining the University of California, San Francisco (UCSF) Brain Health Registry as a cognitive assessment

Cambridge Cognition Holdings Plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that Michael (Mick) Holton will join the Board as an Executive Director with immediate effect. Mick has been serving

Cambridge Cognition Holdings plc (LON:COG) which develops and markets digital solutions to assess brain health, has confirmed that the Annual Report and Accounts for the year ended 31 December 2020 and the Notice of the Annual

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won a contract with a new pharmaceutical client to provide cognitive assessments in an at-home clinical

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won a £1.3 million contract as the cognitive assessment partner for a schizophrenia trial. Revenue from

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital technology to deliver customer-focused solutions to assess brain health, has announced its unaudited preliminary results for the year ended 31 December 2020. Highlights The Company delivered a strong

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that CEO Matthew Stork and CFO Michael Holton will provide a live investor presentation on Tuesday 23 March at 6.00

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced a positive trading update and notice of results for the year ended 31 December 2020, together with details of a forthcoming

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won a new contract with a major pharmaceutical client to provide digital assessments of mood and

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won a new contract providing cognitive tests and electronic clinical outcome assessments for an Alzheimer’s trial.

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that CEO Matthew Stork and CFO Nick Walters will provide a live investor presentation on Wednesday 14 October at 6.00pm

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced its unaudited interim results for the six months ended 30 June 2020. The first half of 2020 saw strong progress in

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that Richard Bungay will join the Board as a Non-Executive Director with immediate effect. Mr. Bungay has over 25

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won a £2m contract as the cognitive assessment partner for three late phase clinical trials for